Global Hearing Aids Market Research Report By Product, By Type of Hear Loss, By Patient Type, By Technology Forecast to 2032
º¸Ã»±â ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 120¾ï 3,401¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ¾ú½À´Ï´Ù. 2025-2032³âÀÇ ¿¹Ãø ±â°£ Áß CAGR ¾à 8.52%·Î ¼ºÀåÇÒ °ÍÀ¸·Î Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù.
¼¼°èÀÇ º¸Ã»±â ½ÃÀåÀº ¸î °¡Áö ±âº» ¿äÀο¡ ÀÇÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼ÀÇ ÁÖ¿ä ÀÌÀ¯ Áß Çϳª´Â ƯÈ÷ ³ë³âÃþ¿¡¼ û·Â ¼Õ½ÇÀÇ ¹ß»ý·üÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. °¢±¹ Á¤ºÎ¿Í º¸°Ç ±â°üÀº û·Â °Ç° ¹®Á¦¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̰í ÀÖÀ¸¸ç, ÀÌ´Â ¼ö¿ä Áõ°¡¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ µðÁöÅÐ º¸Ã»±â °³¹ß ¹× ¹«¼± ¿¬°á ±â´É°ú °°Àº ±â¼ú Çõ½ÅÀ¸·Î ÀÎÇØ Á¦Ç° ¶óÀξ÷ÀÌ È®´ëµÇ¾î ´õ ¸¹Àº °í°´ÃþÀ» ²ø¾îµéÀ̰í ÀÖ½À´Ï´Ù. ¼ÒºñÀÚÀÇ °¡Ã³ºÐ ¼ÒµæÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ´õ ¸¹Àº »ç¶÷µéÀÌ »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â º¸Ã»±â¸¦ ´õ ½±°Ô ±¸ÇÒ ¼ö ÀÖ°ÔµÈ °Íµµ ÇÑ ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
Áö¿ªº° ÀλçÀÌÆ®
ºÏ¹Ì´Â ½ÅÁ¦Ç° Ãâ½Ã, º¸Ã»±â ÆÇ¸Å È®´ë, ¹ÌÀû °¨°¢ÀÌ °ÈµÈ ´«¿¡ Àß ¶çÁö ¾Ê´Â º¸Ã»±â¿¡ ´ëÇÑ ³ôÀº ¼ö¿ë¼º µî ´Ù¾çÇÑ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¶ÇÇÑ À¯·´Àº Á¤ºÎÀÇ °·ÂÇÑ Áö¿ø°ú ÷´Ü º¸Ã»±â °³¹ßÀ» À§ÇÑ ¿¬±¸ Áõ°¡·Î ÀÎÇØ ½ÃÀå Á¡À¯À²¿¡¼ µÎ ¹øÂ°·Î Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº °í·ÉÈ ÁøÇà°ú º¸Ã»±â »ç¿ë È®´ë¿¡ ÈûÀÔ¾î ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°èÀÇ º¸Ã»±â ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ Á¤ÀÇ¿Í °³¿ä, ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ °¢Á¾ ¿µÇâ¿äÀÎÀÇ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÀÌ¡¤¿¹Ãø, °¢Á¾ ±¸ºÐ¡¤Áö¿ª/ÁÖ¿ä ±¹°¡º° ³»¿ª, °æÀï ȯ°æ, ÁÖ¿ä ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
¸ñÂ÷
Á¦1Àå °³¿ä
Á¦2Àå ½ÃÀå °³¿ä
Á¦3Àå Á¶»ç ¹æ¹ý
Á¦4Àå ½ÃÀå ¿ªÇÐ
- ÃËÁø¿äÀÎ
- ³Ã»ÀÇ ¹ß»ý·ü Áõ°¡
- °í·ÉÀÚ Àα¸ÀÇ Áõ°¡
- ¾ïÁ¦¿äÀÎ
- ³ôÀº ºñ¿ë°ú ÀûÁ¤ °¡°Ý ¼ö¿ë¼º ¹®Á¦
- ³Ã»¿¡ ´ëÇÑ Æí°ß°ú »çȸÀû ¼ö¿ë
- ±âȸ
- °¡Ã³ºÐ¼Òµæ°ú ÁÖÅà ±¸ÀÔ ´É·ÂÀÇ »ó½Â
- ±â¼úÀÇ Áøº¸
Á¦5Àå ½ÃÀå ¿äÀÎ ºÐ¼®
- Porter's Five Forces ¸ðµ¨
- COVID-19¿¡ ÀÇÇÑ º¸Ã»±â ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ
- OTC º¸Ã»±â ½ÃÀåÀÇ µ¿Çâ
- °áÁ¦¹æ¹ý ºÐ¼® : Áö¿ªº°
Á¦6Àå ¼¼°èÀÇ º¸Ã»±â ½ÃÀå : Á¦Ç°º°
Á¦7Àå ¼¼°èÀÇ º¸Ã»±â ½ÃÀå : ³Ã» À¯Çüº°
Á¦8Àå ¼¼°èÀÇ º¸Ã»±â ½ÃÀå : ȯÀÚ À¯Çüº°
Á¦9Àå ¼¼°èÀÇ º¸Ã»±â ½ÃÀå : ±â¼úº°
Á¦10Àå ¼¼°èÀÇ º¸Ã»±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°
- Àڱ⠺δã
- ¼µåÆÄƼ º¸ÇèÀÚ
- Medicare/Medicaid
Á¦11Àå ¼¼°èÀÇ º¸Ã»±â ½ÃÀå : Áö¿ªº°
- ºÏ¹Ì
- À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ³²¹Ì
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦12Àå °æÀï ±¸µµ
Á¦13Àå ±â¾÷ °³¿ä
- COCHLEAR LIMITED
- GN HEARING A/S
- SONOVA
- WILLIAM DEMANT HOLDING A/S
- STARKEY
- PETROFAC
- HALLIBURTON
- ZOUNDS HEARING
- AUDINA HEARING INSTRUMENTS
- AMPLIFON
Á¦14Àå µ¥ÀÌÅÍ Àοë
KSA
Global Hearing Aids Market Research Report By Product (Hearing aid devices and Hearing implants), By Type of Hear Loss (Sensorineural hearing loss and Conductive hearing loss), By Patient Type (Adults and Pediatrics), By Technology (Digital and Analog) Forecast to 2032
Market Overview
According to MRFR analysis, the size of the hearing aids market was expected to reach USD 12,034.01 million in 2023. It is projected that the hearing aids market will grow at a compound annual growth rate (CAGR) of roughly 8.52% during the forecast period (2025-2032).
The worldwide hearing aid market is expanding quickly due to several basic factors. One of the main reasons for this trend is the rising incidence of hearing loss, especially among the elderly population. Governments and health organizations worldwide are raising awareness of hearing health issues, which is driving up demand. Furthermore, technological developments such as the creation of digital hearing aids and wireless networking capabilities have expanded product offerings and drawn in a larger customer base. Growing consumer disposable income across a range of industries will make it easier for more people to afford hearing aids that can enhance their quality of life.
Market Segmentation
Hearing implants and hearing aid devices make up the two product-based categories of the global market for hearing aids.
Sensorineural and conductive hearing loss are the two categories into which the global market is separated.
Based on patient types, the market is divided into two segments: pediatrics and adults.
The global market for hearing aids is divided between digital and analog technology.
The market is divided into two divisions based on technology: digital and analog.
The end-user market is divided into three segments: private pay/out-of-pocket, third-party payer, and Medicare/Medicaid.
Regional Insights
The analysis provides market data for hearing aids in North America, Europe, Asia-Pacific, and the rest of the world. North America led the global market in 2023. Due to a variety of factors, including the launch of new products, the expanding volume of sales of hearing devices, and the strong acceptance of less conspicuous devices for higher aesthetic appeal, North America is expected to have the highest growth rate throughout the projection period. With strong government support and increased research into developing advanced hearing aids, Europe is expected to have the second-largest share. The strategic location of several companies in the region, such as GN Store Nord A/S, Senovo, Demant A/S, and WS Audiology, is also expected to support growth. The National Institute for Health and Care Excellence (NICE) estimates that 1,260 people in England currently receive cochlear implants each year. It would also encourage market growth. Asia Pacific is expected to have the highest compound annual growth rate (CAGR) over the projected period due to the aging population and the increasing usage of hearing implants. According to Hear-it.org, there are currently 3.6 billion Australians who suffer from hearing loss; by 2060, that number is expected to increase to 7.8 billion, propelling the country's economic expansion.
Key Players
Among the leading companies in the hearing aids market are Starkey Hearing Technologies, Signia, Oticon, Demant, GN Store Nord, Unitron, Eargo, Cochlear, WS Audiology, Rexton, MED-EL (Medical Electronics), William Demant Holding A/S, Amplifon, Sonova, Audina Hearing Instruments, Beltone, and Hearing Life.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
- 2.1 DEFINITION
- 2.2 SCOPE OF THE STUDY
- 2.3 RESEARCH OBJECTIVE
3 RESEARCH METHODOLOGY
- 3.1 OVERVIEW
- 3.2 DATA FLOW
- 3.2.1 Data Mining Process
- 3.3 PURCHASED DATABASE:
- 3.4 SECONDARY SOURCES:
- 3.4.1 Secondary Research data flow:
- 3.5 PRIMARY RESEARCH:
- 3.5.1 Primary Research DATA FLOW:
- 3.5.2 Primary Research: Number of Interviews conducted
- 3.5.3 Primary Research: Regional Coverage
- 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 3.6.1 Revenue Analysis Approach
- 3.7 DATA FORECASTING
- 3.7.1 Data forecasting Type
- 3.8 DATA MODELING
- 3.8.1 microeconomic factor analysis:
- 3.8.2 Data modeling:
- 3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
- 4.1 INTRODUCTION
- 4.2 DRIVERS
- 4.2.1 Increasing Incidences of Hearing Loss
- 4.2.2 Growth of Elderly/Geriatric Population
- 4.3 RESTRAINTS
- 4.3.1 High Cost and Affordability Issues
- 4.3.2 Stigma and Social Acceptance
- 4.4 OPPORTUNITY
- 4.4.1 Rise in Disposable Income and Affordability
- 4.4.2 Technological Advancements
5 MARKET FACTOR ANALYSIS
- 5.1 PORTER'S FIVE FORCES MODEL
- 5.1.1 Porter's Five Forces Model
- 5.1.1.1 Threat of New Entrants
- 5.1.1.2 Bargaining Power of Suppliers
- 5.1.1.3 Bargaining Power of Buyers
- 5.1.1.4 Threat of Substitutes
- 5.1.1.5 Industry Rivalry
- 5.2 IMPACT OF COVID-19 ON HEARING AIDS MARKET
- 5.3 OTC HEARING AID MARKET TRENDS
- 5.4 PAYMENT MODE ANALYSIS BY REGION
6 GLOBAL HEARING AIDS MARKET, BY PRODUCT
- 6.1 INTRODUCTION
- 6.1.1 Hearing Aid Devices
- 6.1.1.1 Behind-the-ear (BTE) Hearing Aids
- 6.1.1.2 In-the-ear (ITE) Hearing Aids
- 6.1.1.3 Canal Hearing Aids
- 6.1.1.4 Receiver-in-the-ear (RIE) Hearing Aid
- 6.1.1.5 Others
- 6.1.2 Hearing Implants
- 6.1.2.1 Cochlear Implants
- 6.1.2.2 Bone-Anchored Hearing Aids (BAHA)
7 GLOBAL HEARING AIDS MARKET, BY TYPE OF HEARING LOSS
- 7.1 INTRODUCTION
- 7.1.1 Sensorineural Hearing Loss
- 7.1.2 Conductive Hearing Loss
8 GLOBAL HEARING AIDS MARKET, BY PATIENT TYPE
- 8.1 INTRODUCTION
- 8.1.1 Adults
- 8.1.2 Pediatrics
9 GLOBAL HEARING AIDS MARKET, BY TECHNOLOGY
- 9.1 INTRODUCTION
- 9.1.1 Digital
- 9.1.2 Analog
10 GLOBAL HEARING AIDS MARKET, BY END USER
- 10.1 INTRODUCTION
- 10.1.1 Private Pay/Out of Pocket
- 10.1.2 Third Party Payer
- 10.1.3 Medicare/Medicaid
11 GLOBAL HEARING AIDS MARKET, BY REGION
- 11.1 INTRODUCTION
- 11.1.1 North America
- 11.1.1.1 US
- 11.1.1.2 Canada
- 11.1.1.3 Mexico
- 11.1.2 EUROPE
- 11.1.2.1 Germany
- 11.1.2.2 UK
- 11.1.2.3 France
- 11.1.2.4 Italy
- 11.1.2.5 Spain
- 11.1.2.6 Rest Of Europe
- 11.1.3 ASIA-PACIFIC
- 11.1.3.1 Japan
- 11.1.3.2 China
- 11.1.3.3 India
- 11.1.3.4 Australia
- 11.1.3.5 Rest Of Asia Pacific
- 11.1.4 SOUTH AMERICA
- 11.1.4.1 Brazil
- 11.1.4.2 Colombia
- 11.1.4.3 Rest of South America
- 11.1.5 Middle East & Africa
- 11.1.5.1 South Africa
- 11.1.5.2 GCC Countries
- 11.1.5.3 Rest of Middle East and Africa
12 COMPETITIVE LANDSCAPE
- 12.1 INTRODUCTION
- 12.2 MARKET SHARE ANALYSIS, 2023
13 COMPANY PROFILES
- 13.1 COCHLEAR LIMITED
- 13.1.1 COMPANY OVERVIEW
- 13.1.2 PRODUCTS OFFERed
- 13.1.3 SWOT ANALYSIS
- 13.1.4 Key Strategy
- 13.2 GN HEARING A/S
- 13.2.1 COMPANY OVERVIEW
- 13.2.2 PRODUCTS OFFERed
- 13.2.3 SWOT ANALYSIS
- 13.2.4 Key Strategy
- 13.3 SONOVA
- 13.3.1 COMPANY OVERVIEW
- 13.3.2 PRODUCTS OFFERed
- 13.3.3 SWOT ANALYSIS
- 13.3.4 Key Strategy
- 13.4 WILLIAM DEMANT HOLDING A/S
- 13.4.1 COMPANY OVERVIEW
- 13.4.2 PRODUCTS OFFERed
- 13.4.3 SWOT ANALYSIS
- 13.4.4 Key Strategy
- 13.5 STARKEY
- 13.5.1 COMPANY OVERVIEW
- 13.5.2 PRODUCTS OFFERed
- 13.5.3 SWOT ANALYSIS
- 13.5.4 Key Strategy
- 13.6 PETROFAC
- 13.6.1 COMPANY OVERVIEW
- 13.6.2 PRODUCTS OFFERed
- 13.6.3 SWOT ANALYSIS
- 13.6.4 Key Strategy
- 13.7 HALLIBURTON
- 13.7.1 COMPANY OVERVIEW
- 13.7.2 PRODUCTS OFFERed
- 13.7.3 SWOT ANALYSIS
- 13.7.4 Key Strategy
- 13.8 ZOUNDS HEARING
- 13.8.1 COMPANY OVERVIEW
- 13.8.2 PRODUCTS OFFERed
- 13.8.3 SWOT ANALYSIS
- 13.8.4 Key Strategy
- 13.9 AUDINA HEARING INSTRUMENTS
- 13.9.1 COMPANY OVERVIEW
- 13.9.2 PRODUCTS OFFERed
- 13.9.3 SWOT ANALYSIS
- 13.9.4 Key Strategy
- 13.10 AMPLIFON
- 13.10.1 COMPANY OVERVIEW
- 13.10.2 PRODUCTS OFFERed
- 13.10.3 SWOT ANALYSIS
- 13.10.4 Key Strategy
14 DATA CITATIONS